Načítá se...

Plasma marinobufagenin immunoreactivity in patients with chronic kidney disease: a case control study

Experimental data have shown increased plasma levels of marinobufagenin in kidney failure. In this case-controlled retrospective analysis, we evaluated plasma marinobufagenin immunoreactivity in hemodialysis patients compared with subjects with normal kidney function. Sixty-eight adult hemodialysis...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Physiol Renal Physiol
Hlavní autoři: Piecha, Grzegorz, Kujawa-Szewieczek, Agata, Kuczera, Piotr, Skiba, Katarzyna, Sikora-Grabka, Ewelina, Więcek, Andrzej
Médium: Artigo
Jazyk:Inglês
Vydáno: American Physiological Society 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6172577/
https://ncbi.nlm.nih.gov/pubmed/30043626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00046.2018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!